Postexercise phosphocreatine recovery, an index of mitochondrial oxidative phosphorylation, is reduced in diabetic patients with lower extremity complications

Journal of Vascular Surgery

Volumn 57, Issue 4, 2013, Pages 997-1005

  Tecilazich, Francesco ^a   Dinh, Thanh ^a   Lyons, Thomas E ^a   Guest, Julie ^a   Villafuerte, Rosemond A ^b   Sampanis, Christos ^a   Gnardellis, Charalambos ^c   Zuo, Chun S ^b   Veves, Aristidis ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b MCLEAN HOSPITAL   (United States)

^c TECHNOLOGICAL EDUCATIONAL INSTITUTE OF PATRAS   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

COLONY STIMULATING FACTOR; CREATINE PHOSPHATE; OSTEOPROTEGERIN; PHOSPHOROUS ACID; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ANIMAL TISSUE; ARTICLE; CALF (BOVINE); CLINICAL ARTICLE; DIABETIC PATIENT; EXERCISE; FEMALE; GASTROCNEMIUS MUSCLE; HUMAN; MALE; MITOCHONDRION; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; OXIDATIVE PHOSPHORYLATION; PERIPHERAL NEUROPATHY; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRIORITY JOURNAL; SOLEUS MUSCLE;

ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; DIABETIC NEUROPATHIES; EXERCISE; FEMALE; GRANULOCYTE COLONY-STIMULATING FACTOR; HUMANS; INFLAMMATION MEDIATORS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; MITOCHONDRIA; MUSCLE CONTRACTION; MUSCLE, SKELETAL; OSTEOPROTEGERIN; OXIDATIVE PHOSPHORYLATION; PERIPHERAL ARTERIAL DISEASE; PHOSPHOCREATINE; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84875447469     PISSN: 07415214     EISSN: 10976809     Source Type: Journal    
DOI: 10.1016/j.jvs.2012.10.011     Document Type: Article

References (37)

1. I.I. Pipinos, A.D. Shepard, P.V. Anagnostopoulos, A. Katsamouris, and M.D. Boska Phosphorus 31 nuclear magnetic resonance spectroscopy suggests a mitochondrial defect in claudicating skeletal muscle J Vasc Surg 31 2000 944 952
2. A. Greiner, R. Esterhammer, S. Pilav, W. Arnold, W. Santner, and B. Neuhauser High-energy phosphate metabolism in the calf muscle during moderate isotonic exercise under different degrees of cuff compression: a phosphorus 31 magnetic resonance spectroscopy study J Vasc Surg 42 2005 259 267
3. A. Greiner, R. Esterhammer, H. Messner, M. Biebl, H. Muhlthaler, and G. Fraedrich High-energy phosphate metabolism during incremental calf exercise in patients with unilaterally symptomatic peripheral arterial disease measured by phosphor 31 magnetic resonance spectroscopy J Vasc Surg 43 2006 978 986
4. I.I. Pipinos, A.R. Judge, Z. Zhu, J.T. Selsby, S.A. Swanson, and J.M. Johanning Mitochondrial defects and oxidative damage in patients with peripheral arterial disease Free Radic Biol Med 41 2006 262 269
5. I.I. Pipinos, V.G. Sharov, A.D. Shepard, P.V. Anagnostopoulos, A. Katsamouris, and A. Todor Abnormal mitochondrial respiration in skeletal muscle in patients with peripheral arterial disease J Vasc Surg 38 2003 827 832
6. J.D. Anderson, F.H. Epstein, C.H. Meyer, K.D. Hagspiel, H. Wang, and S.S. Berr Multifactorial determinants of functional capacity in peripheral arterial disease: uncoupling of calf muscle perfusion and metabolism J Am Coll Cardiol 54 2009 628 635
7. A. Sleigh, P. Raymond-Barker, K. Thackray, D. Porter, M. Hatunic, and A. Vottero Mitochondrial dysfunction in patients with primary congenital insulin resistance J Clin Invest 121 2011 2457 2461
8. V.B. Schrauwen-Hinderling, M.E. Kooi, M.K. Hesselink, J.A. Jeneson, W.H. Backes, and C.J. van Echteld Impaired in vivo mitochondrial function but similar intramyocellular lipid content in patients with type 2 diabetes mellitus and BMI-matched control subjects Diabetologia 50 2007 113 120
9. A. Sleigh, A. Stears, K. Thackray, L. Watson, A. Gambineri, and S. Nag Mitochondrial oxidative phosphorylation is impaired in patients with congenital lipodystrophy J Clin Endocrinol Metab 97 2012 E438 E442
10. H.M. De Feyter, N.M. van den Broek, S.F. Praet, K. Nicolay, L.J. van Loon, and J.J. Prompers Early or advanced stage type 2 diabetes is not accompanied by in vivo skeletal muscle mitochondrial dysfunction Eur J Endocrinol 158 2008 643 653
11. P. Fernyhough, S.K. Roy Chowdhury, and R.E. Schmidt Mitochondrial stress and the pathogenesis of diabetic neuropathy Expert Rev Endocrinol Metab 5 2010 39 49
12. E. Akude, E. Zherebitskaya, S.K. Chowdhury, D.R. Smith, R.T. Dobrowsky, and P. Fernyhough Diminished superoxide generation is associated with respiratory chain dysfunction and changes in the mitochondrial proteome of sensory neurons from diabetic rats Diabetes 60 2011 288 297
13. A.M. Vincent, J.L. Edwards, L.L. McLean, Y. Hong, F. Cerri, and I. Lopez Mitochondrial biogenesis and fission in axons in cell culture and animal models of diabetic neuropathy Acta Neuropathol 120 2010 477 489
14. H. Chao, J.L. Bowers, D. Holtzman, and R.V. Mulkern RARE imaging of PCr in human forearm muscles J Magn Reson Imaging 7 1997 1048 1055
15. G.J. Kemp, D.J. Taylor, and G.K. Radda Control of phosphocreatine resynthesis during recovery from exercise in human skeletal muscle NMR Biomed 6 1993 66 72
16. S. Arora, P. Smakowski, R.G. Frykberg, L.R. Simeone, R. Freeman, and F.W. LoGerfo Differences in foot and forearm skin microcirculation in diabetic patients with and without neuropathy Diabetes Care 21 1998 1339 1344
17. A.T. Hirsch, Z.J. Haskal, N.R. Hertzer, C.W. Bakal, M.A. Creager, and J.L. Halperin ACC/AHA 2005 practice guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease): endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation Circulation 113 2006 e463 e654
18. R.L. Greenman, S. Panasyuk, X. Wang, T.E. Lyons, T. Dinh, and L. Longoria Early changes in the skin microcirculation and muscle metabolism of the diabetic foot Lancet 366 2005 1711 1717
19. M.C. Corretti, T.J. Anderson, E.J. Benjamin, D. Celermajer, F. Charbonneau, and M.A. Creager Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force J Am Coll Cardiol 39 2002 257 265
20. T. Dinh, J. Doupis, T.E. Lyons, S. Kuchibhotla, W. Julliard, and C. Gnardellis Foot muscle energy reserves in diabetic patients without and with clinical peripheral neuropathy Diabetes Care 32 2009 1521 1524
21. P.A. Economides, A. Caselli, E. Tiani, L. Khaodhiar, E.S. Horton, and A. Veves The effects of atorvastatin on endothelial function in diabetic patients and subjects at risk for type 2 diabetes J Clin Endocrinol Metab 89 2004 740 747
22. D.R. Matthews, J.P. Hosker, A.S. Rudenski, B.A. Naylor, D.F. Treacher, and R.C. Turner Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man Diabetologia 28 1985 412 419
23. A.E. Caballero, S. Arora, R. Saouaf, S.C. Lim, P. Smakowski, and J.Y. Park Microvascular and macrovascular reactivity is reduced in subjects at risk for type 2 diabetes Diabetes 48 1999 1856 1862
24. A. Achilli, A. Olivieri, M. Pala, B. Hooshiar Kashani, V. Carossa, and U.A. Perego Mitochondrial DNA backgrounds might modulate diabetes complications rather than T2DM as a whole PLoS One 6 2011 e21029
25. J.I. Odegaard, R.R. Ricardo-Gonzalez, M.H. Goforth, C.R. Morel, V. Subramanian, and L. Mukundan Macrophage-specific PPARgamma controls alternative activation and improves insulin resistance Nature 447 2007 1116 1120
26. J. Doupis, T.E. Lyons, S. Wu, C. Gnardellis, T. Dinh, and A. Veves Microvascular reactivity and inflammatory cytokines in painful and painless peripheral diabetic neuropathy J Clin Endocrinol Metab 94 2009 2157 2163
27. M.A. Niewczas, L.H. Ficociello, A.C. Johnson, W. Walker, E.T. Rosolowsky, and B. Roshan Serum concentrations of markers of TNFalpha and Fas-mediated pathways and renal function in nonproteinuric patients with type 1 diabetes Clin J Am Soc Nephrol 4 2009 62 70
28. T. Coutinho, M. Al-Omari, T.H. Mosley Jr., and I.J. Kullo Biomarkers of left ventricular hypertrophy and remodeling in blacks Hypertension 58 2011 920 925
29. S.M. Venuraju, A. Yerramasu, R. Corder, and A. Lahiri Osteoprotegerin as a predictor of coronary artery disease and cardiovascular mortality and morbidity J Am Coll Cardiol 55 2010 2049 2061
30. S.A. Vetrone, E. Montecino-Rodriguez, E. Kudryashova, I. Kramerova, E.P. Hoffman, and S.D. Liu Osteopontin promotes fibrosis in dystrophic mouse muscle by modulating immune cell subsets and intramuscular TGF-beta J Clin Invest 119 2009 1583 1594
31. A. Hirata, S. Masuda, T. Tamura, K. Kai, K. Ojima, and A. Fukase Expression profiling of cytokines and related genes in regenerating skeletal muscle after cardiotoxin injection: a role for osteopontin Am J Pathol 163 2003 203 215
32. R.L. Greenman, L. Khaodhiar, C. Lima, T. Dinh, J.M. Giurini, and A. Veves Foot small muscle atrophy is present before the detection of clinical neuropathy Diabetes Care 28 2005 1425 1430
33. K.F. Petersen, S. Dufour, D. Befroy, R. Garcia, and G.I. Shulman Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes N Engl J Med 350 2004 664 671
34. D.J. Taylor, P.J. Bore, P. Styles, D.G. Gadian, and G.K. Radda Bioenergetics of intact human muscle. A 31P nuclear magnetic resonance study Mol Biol Med 1 1983 77 94
35. M.F. Schocke, R. Esterhammer, W. Arnold, C. Kammerlander, M. Burtscher, and G. Fraedrich High-energy phosphate metabolism during two bouts of progressive calf exercise in humans measured by phosphorus-31 magnetic resonance spectroscopy Eur J Appl Physiol 93 2005 469 479
36. H. Karakelides, Y.W. Asmann, M.L. Bigelow, K.R. Short, K. Dhatariya, and J. Coenen-Schimke Effect of insulin deprivation on muscle mitochondrial ATP production and gene transcript levels in type 1 diabetic subjects Diabetes 56 2007 2683 2689
37. D.C. Isbell, S.S. Berr, A.Y. Toledano, F.H. Epstein, C.H. Meyer, and W.J. Rogers Delayed calf muscle phosphocreatine recovery after exercise identifies peripheral arterial disease J Am Coll Cardiol 47 2006 2289 2295